Trevena, Inc. Provides Update on Commercial Launch Activities for OLINVYK™ and Announces Anticipated Pipeline Catalysts Jan 06, 2021 7:00am EST
Trevena, Inc. Announces Presentations Highlighting Novel S1P1 Receptor Modulator at the American College of Neuropsychopharmacology 59th Annual Meeting Dec 10, 2020 8:43am EST
Trevena, Inc. Announces Publication Highlighting GI Tolerability Profile of OLINVYK™ (oliceridine) injection in Pain and Therapy Nov 20, 2020 7:00am EST
Trevena, Inc. to Participate in the Following November Virtual Investor Conferences Nov 09, 2020 7:00am EST
Trevena, Inc. Announces Three OLINVYK™ Presentations at the Virtual American Society of Anesthesiologists 2020 Annual Meeting Oct 05, 2020 7:00am EDT
Trevena, Inc. Announces Presentations at the Virtual 2020 American College of Clinical Pharmacology Annual Meeting Sep 21, 2020 7:00am EDT
Trevena Announces Publications of OLINVYK™ Respiratory Safety Analyses vs. IV Morphine Aug 26, 2020 7:00am EDT
Trevena Announces Initiation of TRV027 Study in COVID-19 Patients in Collaboration With Imperial College London Aug 24, 2020 7:00am EDT
